Journal: Scandinavian Journal of Immunology
Article Title: Inhibition of Alternative and Terminal Complement Pathway Components Modulate the Immune Response Against Bacteria and Fungi in Whole Blood
doi: 10.1111/sji.70030
Figure Lengend Snippet: Complement activation in E. coli and A. fumigatus –stimulated whole blood. Analysis of complement activation in whole blood, as assessed by activation products C4c (A, B), C3bc (C, D), and sC5b‐9 (E, F), utilising either E. coli (A, C, E) or A. fumigatus conidia (B, D, F) as a stimulating agent. Multiple controls, including a baseline control (Tb; no incubation, no stimulation), an incubation control (T30; incubation, no stimulation), and a stimulation control (T30stim; incubation, stimulation) are included to assess the model‐dependent complement activation progression. Individually targeted components of the complement system include FD, C3, C5, and C5aR1, with an IgG1 control for reference. The presented data are based on six individual repeats featuring a different healthy donor per repeat. Data are presented as mean with one‐sided SD for better visibility.
Article Snippet: HI A. fumigatus conidia and HI E. coli were added to 15 mL sterile falcon tubes (Sarstedt, Nümbrecht, Germany, cat. no.: 62.554.502), containing 5 mL of 1 M sodium bicarbonate buffer (Merck, cat. no.: S5761; in‐house adjusted to pH 9.0).
Techniques: Activation Assay, Control, Incubation